Professor Egeberg will start in his new role January 1, 2024.

Professor Alexander Egeberg is LEO Pharma’s new Vice President, Head of Global Medical Affairs. The announcement was made ahead of the upcoming 32nd European Academy of Dermatology and Venereology (EADV) Congress.

Alexander Egeberg joins LEO Pharma from his role as professor of dermatology at the University of Copenhagen and head of a clinic in Northern Europe for biologic therapy at Bispebjerg Hospital's Department of Dermatology. He has worked in Medical Affairs at Pfizer and as a consultant for additional global pharma companies.

Professor Egeberg will start in his new role January 1, 2024. He will remain affiliated with the Department of Dermatology at Bispebjerg Hospital, and the University of Copenhagen.

“Medical dermatology is a rapidly evolving field, yet there are still many diseases with few or no good treatment options,” says Egeberg in a news release. “LEO Pharma has a proud 115-year legacy in dermatology, but their ambition and transformative journey is beyond exhilarating. I look very much forward to applying my experience and perspective to support the company’s commitment to advancing care for patients with dermatological diseases.”

Becki Morison, EVP Global Product Strategy and International Operations with LEO Pharma adds: “Alexander will certainly strengthen a dermatologic mindset across our organization and ensure that we always put patient needs at the core as we continue to make a fundamental difference for those who need us most in medical dermatology,” she says.